Work

Molecular Characterization and Clinical Correlations of MEK1/2 Inhibition (AZD6244) in Relapse or Refractory Multiple Myeloma: Analysis From a Phase II Study

Year: 2011

Type: article

Source: Blood

DOI: 10.1182/blood.v118.21.306.306

Authors: Adriana Zingone, Neha Korde, Jinqiu Chen, Liqiang Xi, Mark Raffeld, Beata Holkova, Maciej Kmieciak, Daniel Sullivan, Austin Doyle, Irina Maric, Katherine Calvo, Mary Ann Yancey, Marcia Mulquin, Christina Annunziata, Steven Grant, Ola Landgren

Institutions: National Institutes of Health, National Cancer Institute, VCU Massey Comprehensive Cancer Center, Moffitt Cancer Center, National Institutes of Health Clinical Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2465021744

FWCI: 0.189

Cites:

Cited by: 1

Related to: 10